ZIVO Bioscience, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
ZIVO Over the counter 2840 www.zivobioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ZIVO Bioscience, Inc.

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry - Jun 20th, 2025 6:00 am
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - May 6th, 2025 3:54 pm
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Feb 6th, 2025 2:36 pm
ZIVO Bioscience to Present at The Microcap Conference 2025 - Jan 22nd, 2025 2:15 pm
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Dec 23rd, 2024 6:00 am
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Dec 20th, 2024 7:29 am
Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO) - Aug 23rd, 2024 5:01 pm
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens - Aug 23rd, 2024 9:39 am
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens - Jul 8th, 2024 6:00 am